Effect of Medical Beer on COVID-19

Investigating the effect of Medical Beer on the fever of patients with COVID-19

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200428047229N1

Enrollment

Registered

2020-06-27

Start date

2020-03-29

Completion date

Unknown

Last updated

2020-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

covid-19. COVID-19, virus identified

Interventions

Intervention 1: Intervention group: Patients in this group receive the treatment of COVID-19 according to the protocol of the Ministry of Health, in addition they should recieve daily a glass of medi

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Patients aged 18 to 70 years with inpatient clinical criteria (fever = 38% or severe cough or shortness of breath or respiratory rate = 24 per minute or oxygen saturation <93%) Positive PCR Lung involvement in CT scan of the chest

Exclusion criteria

Exclusion criteria: Previous COVID-19 treatment Allergies and asthma High blood pressure Diabetes Pregnancy Breastfeeding Heart failure Chronic renal failure Get chemotherapy Get Corticostroids Immune deficiency Patient request Need to be admitted to the ICU

Design outcomes

Primary

Measure	Time frame
Fever. Timepoint: At the beginning of the study (before the start of the intervention) and on days 3 and 5 after the start of the medical beer. Method of measurement: Mercury thermometer (oral).	—

Secondary

Measure	Time frame
Muscular pain. Timepoint: At the beginning of the study (before the start of the intervention) and on days 3 and 5 after the start of the medical beer. Method of measurement: By asking the patient and the Visual Analog Scale (VAS) score.;Dry cough. Timepoint: At the beginning of the study (before the start of the intervention) and on days 3 and 5 after the start of the medical beer. Method of measurement: By asking the patient.;Dyspnea. Timepoint: At the beginning of the study (before the start of the intervention) and on days 3 and 5 after the start of the medical beer. Method of measurement: By asking the patient.;ESR. Timepoint: At the beginning of the study (before the start of the intervention) and on day 5 after the start of the medical beer. Method of measurement: Sed rate device.;CRP. Timepoint: At the beginning of the study (before the start of the intervention) and on day 5 after the start of the medical beer. Method of measurement: Agglutination kit.;Blood cell count. Timepoint: At the beginning of the study (before the start of the intervention) and on day 5 after the start of the medical beer. Method of measurement: Cell Counter device.;Chest X-ray. Timepoint: At the beginning of the study (before the start of the intervention) and on the 5th day after the start of the medical beer. Method of measurement: Radiology set.;Chest CT scan. Timepoint: At the beginning of the study (before the start of the intervention) and on day 5, if requested by the treating physician, it will be recorded. Method of measurement: CT scan set.	—

Measure

Time frame

Muscular pain. Timepoint: At the beginning of the study (before the start of the intervention) and on days 3 and 5 after the start of the medical beer. Method of measurement: By asking the patient and the Visual Analog Scale (VAS) score.;Dry cough. Timepoint: At the beginning of the study (before the start of the intervention) and on days 3 and 5 after the start of the medical beer. Method of measurement: By asking the patient.;Dyspnea. Timepoint: At the beginning of the study (before the start of the intervention) and on days 3 and 5 after the start of the medical beer. Method of measurement: By asking the patient.;ESR. Timepoint: At the beginning of the study (before the start of the intervention) and on day 5 after the start of the medical beer. Method of measurement: Sed rate device.;CRP. Timepoint: At the beginning of the study (before the start of the intervention) and on day 5 after the start of the medical beer. Method of measurement: Agglutination kit.;Blood cell count. Timepoint: At the beginning of the study (before the start of the intervention) and on day 5 after the start of the medical beer. Method of measurement: Cell Counter device.;Chest X-ray. Timepoint: At the beginning of the study (before the start of the intervention) and on the 5th day after the start of the medical beer. Method of measurement: Radiology set.;Chest CT scan. Timepoint: At the beginning of the study (before the start of the intervention) and on day 5, if requested by the treating physician, it will be recorded. Method of measurement: CT scan set.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHanieh Tahermohammadi

Shahid Beheshti University of Medical Sciences

dr.hmohammadi@sbmu.ac.ir+98 21 8877 3521

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026